SEARCH

SEARCH BY CITATION

References

  • Antoine, J.-C., Jouanne, C., and Ryter, A. (1989) Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes. Parasitology 99: 19.
  • Antoine, J.-C., Jouanne, C., Lang, T., Prina, E., De Chastellier, C., and Frehel, C. (1991) Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun 59: 764775.
  • Berman, J.D. (1984) Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation. J Parasitol 70: 561562.
  • Blackwell, J.M. (1996) Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112: S67S74.
  • Buckner, F.S., Verlinde, C.L., La Flamme, A.C., and Van Voorhis, W.C. (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40: 25922597.
  • Buffet, P.A., Sulahian, A., Garin, Y.J., Nassar, N., and Derouin, F. (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39: 21672168.
  • Callahan, H.L., Portal, A.C., Devereaux, R., and Grogl, M. (1997) An axenic amastigote system for drug screening. Antimicrob Agents Chemother 41: 818822.
  • Chan, M.M.Y., Bulinski, J.C., Chang, K.P., and Fong, D. (2003) A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitol Res 89: 266271.
  • Collins, L.A., Torrero, M.N., and Franzblau, S.G. (1998) Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother 42: 344347.
  • Contag, C.H., Contag, P.R., Mullins, J.I., Spilman, S.D., Stevenson, D.K., and Benaron, D.A. (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593603.
  • Courret, N., Fréhel, C., Prina, E., Lang, T., and Antoine, J.-C. (2001) Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122: 263279.
  • Courret, N., Lang, T., Milon, G., and Antoine, J.C. (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 13731383.
  • Deb, D.K., Srivastava, K.K., Srivastava, R., and Srivastava, B.S. (2000) Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages. Biochem Bioph Res Co 279: 457461.
  • Doyle, T.C., Burns, S.M., and Contag, C.H. (2004) In vivo bioluminescence imaging for integrated studies of infection. Cellular Microbiol 6: 303317.
  • Edinger, M., Hoffmann, P., Contag, C.H., and Negrin, R.S. (2003) Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods 31: 172179.
  • Ephros, M., Bitnun, A., Shaked, P., Waldman, E., and Zilberstein, D. (1999) Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 43: 278282.
  • Fakhfakh, M.A., Fournet, A., Prina, E., Mouscadet, J.F., Franck, X., Hocquemiller, R., and Figadere, B. (2003) Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11: 50135023.
  • Francis, K.P., Joh, D., Bellinger-Kawahara, C., Hawkinson, M.J., Purchio, T.F., and Contag, P.R. (2000) Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68: 35943600.
  • Francis, K.P., Yu, J., Bellinger-Kawahara, C., Joh, D., Hawkinson, M.J., Xiao, G., et al. (2001) Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 69: 33503358.
  • Goyard, S., Segawa, H., Gordon, J., Showalter, M., Duncan, R., Turco, S.J., and Beverley, S.M. (2003) An in vitro system for developmental and genetic studies of *Leishmania* donovani phosphoglycans. Mol Biochem Parasitol 130: 3142.
  • Greer, L.F., and Szalay, A.A. (2002) Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17: 4374.
  • Handman, E. (2001) Leishmaniasis: Current Status of Vaccine Development. Clin Microbiol Rev 14: 229243.
  • Jacobs, W.R., Barletta, R.G., Udani, R., Chan, J., Kalkut, G., Sosne, G., et al. (1993) Rapid assessment of drug susceptibilities of mycobacterium-tuberculosis by means of Luciferase Reporter Phages. Science 260: 819822.
  • Kadurugamuwa, J.L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., et al. (2003) Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71: 882890.
  • Katakura, K., Kawazu, S., Naya, T., Nagakura, K., Ito, M., Aikawa, M., et al. (1998) Diagnosis of kala-azar by nested PCR based on amplification of the Leishmania mini-exon gene. J Clin Microbiol 36: 21732177.
  • Launois, P., Louis, J.A., and Milon, G. (1997) The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology 115: S25S32.
  • Leclercq, V., Lebastard, M., Belkaid, Y., Louis, J., and Milon, G. (1996) The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol 157: 45374545.
  • Loimaranta, V., Tenovuo, J., Koivisto, L., and Karp, M. (1998) Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob Agents Chemother 42: 19061910.
  • Luker, G.D., Bardill, J.P., Prior, J.L., Pica, C.M., Piwnica-Worms, D., and Leib, D.A. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76: 1214912161.
  • Luque-Ortega, J.R., Rivero-Lezcano, O.M., Croft, S.L., and Rivas, L. (2001) In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism. Antimicrob Agents Chemother 45: 11211125.
  • Misslitz, A., Mottram, J.C., Overath, P., and Aebischer, T. (2000) Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasitol 107: 251261.
  • Nicolas, L., Milon, G., and Prina, E. (2002) Rapid differentiation of Old World Leishmania species by LightCycler polymerase chain reaction and melting curve analysis. J Microbiol Methods 51: 295299.
  • Noyes, H.A., Reyburn, H., Bailey, J.W., and Smith, D. (1998) A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan. [see comments]J Clin Microbiol 36: 28772881.
  • Prina, E., Jouanne, C., De Souza Lao, S., Szabo, A., Guillet, J.G., and Antoine, J.-C. (1993) Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol 151: 20502061.
  • Rocchetta, H.L., Boylan, C.J., Foley, J.W., Iversen, P.W., Letourneau, D.L., McMillian, C.L., et al. (2001) Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother 45: 129137.
  • Roy, G., Dumas, C., Sereno, D., Wu, Y., Singh, A.K., Tremblay, M.J., et al. (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110: 195206.
  • Sereno, D., Cavaleyra, M., Zemzoumi, K., Maquaire, S., Ouaissi, A., and Lemesre, J.L. (1998) Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother 42: 30973102.
  • Sereno, D., Roy, G., Lemesre, J.L., Papadopoulou, B., and Ouellette, M. (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45: 11681173.
  • Sorensen, M., Lippuner, C., Kaiser, T., Misslitz, A., Aebischer, T., and Bumann, D. (2003) Rapidly maturing red fluorescent protein variants with strongly enhanced brightness in bacteria. FEBS Lett 552: 110114.
  • Spath, G.F., and Beverley, S.M. (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97103.
  • Strijbosch, L.W., Buurman, W.A., Does, R.J., Zinken, P.H., and Groenewegen, G. (1987) Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods 97: 133140.
  • Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126: 16141619.
  • Titus, R.G., Marchand, M., Boon, T., and Louis, J.A. (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545555.